Evaluation of Treatment Efficacy by Circulating Tumor Cell Phenotype Surveillance in Breast Cancer Patients
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-75
SponsorHunan Cancer Hospital
About this trial
The phenotype of circulating tumor cells (CTCs) is supposed to be significant indicator that is correlated the prognosis of breast cancer patients who have completed neoadjuvant chemotherapy, primary tumor surgery with/without adjuvant chemotherapy. The aim of this observational study is to assess the efficacy of CTCs surveillance in predicting the prognosis of breast cancer patients.
Eligibility criteria
Qualifiers
The age is more than 18 years old;
Pathology confirmed malignant breast tumor;
No clinical diagnosis of other malignancies, unstable complications or uncontrolled infection;
Life expectancy is greater than 6 month;
Disqualifiers
Patients who had suffered from other malignant tumors;
With uncontrolled bacterial, viral or fungal infections;
With physical or mental disorders
Without or limited civil capacity;
Trial design
Treatments tested in this trial
- CTC detection
Treatment groups
1,000 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov